Teishima J, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, et al. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. CUAJ [Internet]. 2020 Jun. 5 [cited 2026 Apr. 27];14(11):E582-7. Available from: https://cuaj.ca/index.php/journal/article/view/6413